17430582

Source:http://linkedlifedata.com/resource/pubmed/id/17430582

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010583, umls-concept:C0013089, umls-concept:C0017262, umls-concept:C0085533, umls-concept:C0144576, umls-concept:C0185117, umls-concept:C0220901, umls-concept:C0237881, umls-concept:C0278487, umls-concept:C0332283, umls-concept:C0376515, umls-concept:C0750502, umls-concept:C1514756, umls-concept:C1516213, umls-concept:C2911684
pubmed:dateCreated	2007-5-2
pubmed:abstractText	Bcl-2 is positively regulated by hormonal receptor pathways in breast cancer. A study was conducted to assess the prognostic significances of clinico-pathologic variables and of ER, PR, p53, c-erbB2, bcl-2, or Ki-67 as markers of relapse in breast cancer patients who had received the identical adjuvant therapy at a single institution.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-10914720, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-10942052, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-10963602, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-11121461, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-11156254, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-11553815, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-11895913, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-12170763, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-12490681, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-12637460, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-12815160, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-15643508, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-15897552, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-15930421, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-16236737, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-16236738, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-16257797, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-16638854, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-16707747, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-16839413, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-1757079, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-1987477, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-7641210, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-8183579, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-8679463, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-9164202, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-9179126, http://linkedlifedata.com/resource/pubmed/commentcorrection/17430582-9194558
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:BangYung-JueYJ, pubmed-author:ChieEui KyuEK, pubmed-author:HaSung WhanSW, pubmed-author:HanWonshikW, pubmed-author:HeoDae SeogDS, pubmed-author:ImSeock-AhSA, pubmed-author:KimDong-WanDW, pubmed-author:KimTae-YouTY, pubmed-author:LeeKyung-HunKH, pubmed-author:LeeSe-HoonSH, pubmed-author:NohDong-YoungDY, pubmed-author:OhDo-YounDY, pubmed-author:ParkIn AeIA
pubmed:issnType	Electronic
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	63
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:17430582-Humans, pubmed-meshheading:17430582-Follow-Up Studies, pubmed-meshheading:17430582-Breast Neoplasms, pubmed-meshheading:17430582-Aged, pubmed-meshheading:17430582-Prognosis, pubmed-meshheading:17430582-Female, pubmed-meshheading:17430582-Adult, pubmed-meshheading:17430582-Neoplasm Metastasis, pubmed-meshheading:17430582-Middle Aged, pubmed-meshheading:17430582-Lymph Node Excision, pubmed-meshheading:17430582-Neoplasm Recurrence, Local, pubmed-meshheading:17430582-Cyclophosphamide, pubmed-meshheading:17430582-Combined Modality Therapy, pubmed-meshheading:17430582-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17430582-Neoplasm Staging, pubmed-meshheading:17430582-Drug Administration Schedule, pubmed-meshheading:17430582-Cohort Studies, pubmed-meshheading:17430582-Tumor Markers, Biological, pubmed-meshheading:17430582-Survival Analysis